Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALPN | ZTS | TAK | CTLT | UTHR |
| Company | Alpine Immune Sciences Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Catalent Inc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NASDAQ |
| Open | 64.42 | 153.01 | 13.18 | 56.01 | 232.94 |
| High | 64.50 | 153.18 | 13.18 | 56.16 | 237.64 |
| Low | 64.42 | 151.24 | 13.11 | 55.57 | 232.84 |
| Last | 64.46 | 151.94 | 13.15 | 55.96 | 235.31 |
| Change | -0.04 | -1.08 | -0.08 | +0.18 | +3.53 |
| % Change | -0.06% | -0.71% | -0.60% | +0.32% | +1.52% |
| Volume | 2,633,300 | 3,270,500 | 1,639,800 | 1,942,900 | 372,400 |
| 20-Day Average Volume | 3,875,950 | 3,840,705 | 1,869,415 | 1,630,340 | 517,880 |
| Previous Close | 64.50 | 153.02 | 13.23 | 55.78 | 231.78 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 45.44 | 163.46 | 13.76 | 56.40 | 235.80 |
| 20-Day Raw Stochastic | 99.64% | 13.38% | 2.78% | 23.93% | 46.93% |
| 20-Day Relative Strength | 80.82% | 29.68% | 32.48% | 50.23% | 51.92% |
| Weighted Alpha | +326.54 | -19.93 | -22.43 | +47.80 | +3.88 |
| Today's Opinion | 100% Buy | 88% Sell | 100% Sell | 40% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 100% Sell | 40% Buy | 80% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 40% Sell | 88% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +37.03% since 04/10/24 | -6.90% since 04/10/24 | -3.10% since 04/10/24 | -1.86% since 04/10/24 | -1.04% since 04/10/24 |
| Low | 64.15 on 04/11/24 | 148.48 on 04/12/24 | 13.11 on 04/17/24 | 55.57 on 04/17/24 | 230.39 on 04/16/24 |
| High | 64.57 on 04/12/24 | 164.29 on 04/11/24 | 13.60 on 04/11/24 | 57.20 on 04/11/24 | 241.37 on 04/11/24 |
| 1-Month | |||||
| %Chg | +77.19% since 03/15/24 | -11.95% since 03/15/24 | -9.12% since 03/15/24 | -0.46% since 03/15/24 | -0.20% since 03/15/24 |
| Low | 34.25 on 04/08/24 | 148.48 on 04/12/24 | 13.11 on 04/17/24 | 55.57 on 04/17/24 | 221.53 on 04/01/24 |
| High | 64.57 on 04/12/24 | 174.33 on 03/21/24 | 14.61 on 03/18/24 | 57.20 on 04/11/24 | 250.89 on 03/26/24 |
| 3-Month | |||||
| %Chg | +217.07% since 01/17/24 | -20.41% since 01/17/24 | -11.51% since 01/17/24 | +15.19% since 01/17/24 | +5.88% since 01/17/24 |
| Low | 18.56 on 01/24/24 | 148.48 on 04/12/24 | 13.11 on 04/17/24 | 47.86 on 01/19/24 | 208.62 on 02/08/24 |
| High | 64.57 on 04/12/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 60.20 on 02/05/24 | 250.89 on 03/26/24 |
| 6-Month | |||||
| %Chg | +531.96% since 10/17/23 | -12.81% since 10/17/23 | -11.80% since 10/17/23 | +22.42% since 10/17/23 | -0.62% since 10/17/23 |
| Low | 8.33 on 10/26/23 | 148.48 on 04/12/24 | 13.11 on 04/17/24 | 31.80 on 11/01/23 | 208.62 on 02/08/24 |
| High | 64.57 on 04/12/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 60.20 on 02/05/24 | 258.31 on 12/14/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,225,095 | 69,491,128 | 41,617,356 | 10,127,304 | 11,073,451 |
| Shares Outstanding, K | 65,546 | 457,359 | 3,164,818 | 180,974 | 47,059 |
| Annual Sales | 58,880,000 | 8,544,000,000 | 29,803,340,000 | 4,263,000,000 | 2,327,500,000 |
| Annual Net Income | -32,180,000 | 2,344,000,000 | 2,345,930,000 | -256,000,000 | 984,800,000 |
| Last Quarter Sales | 30,850,000 | 2,213,000,000 | 7,556,070,000 | 1,024,000,000 | 614,700,000 |
| Last Quarter Net Income | 5,960,000 | 525,000,000 | 718,900,000 | -206,000,000 | 217,100,000 |
| 60-Month Beta | 1.14 | 0.85 | 0.53 | 1.20 | 0.52 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.15 on 03/18/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | -0.24 on 02/09/24 | 4.36 on 02/21/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/09/24 | 06/10/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.76 | 6.78 | 0.00 | 11.68 |